Encapsulation of a glycosaminoglycan in hydroxyapatite/alginate capsules

Journal of Biomedical Materials Research - Part A

Volumn 91, Issue 3, 2009, Pages 866-877

  Tan, Chong Shuan ^a   Jejurikar, Aparna ^a   Rai, Bina ^a   Bostrom, Thor ^b   Lawrie, Gwen ^a   Grøndahl, Lisbeth ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Alginate; Controlled release; Heparin; Hydrogel; Hydroxyapatite; Release mechanism

Indexed keywords

ALGINATE HYDROGELS; ALGINATE MATRIX; BONE GROWTH; BONE REPAIR; CALCIUM ALGINATE; COMPOSITE BEADS; CONTROLLED RELEASE; DELIVERY VEHICLE; DESTABILIZING EFFECT; DRUG DELIVERY VEHICLES; DRUG LOADING; GLYCOSAMINOGLYCANS; HEPARIN; HIGH STABILITY; IN-VITRO; POLYMERIC FLOCCULATION; RELEASE MECHANISM; RELEASE MEDIA; RELEASE PROCESS;

ALGINATE; APATITE; BIOLOGICAL MATERIALS; BONE; CALCIUM; DRUG DELIVERY; ENCAPSULATION; FLOCCULATION; HYDROGELS; HYDROXYAPATITE; HYDROXYLATION; POLYMER MATRIX COMPOSITES; VISCOSITY;

POLYSACCHARIDES;

ALGINIC ACID; GLYCOSAMINOGLYCAN; HEPARIN; HYDROXYAPATITE;

ARTICLE; DRUG DELIVERY SYSTEM; ENCAPSULATION; FLUORESCENCE MICROSCOPY; HYDROGEL; SCANNING ELECTRON MICROSCOPY;

ALGINATES; BIOCOMPATIBLE MATERIALS; BONE AND BONES; BONE SUBSTITUTES; CAPSULES; DURAPATITE; GLYCOSAMINOGLYCANS; HEPARIN; HUMANS; HYDROGEL; HYDROGELS; KINETICS; MATERIALS TESTING; STRESS, MECHANICAL; VISCOSITY;

EID: 70350345555     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32297     Document Type: Article

References (48)

1. Chung YI, Ahn KM, Jeon SH, Lee SY, Lee JH, Tae G. Enhanced bone regeneration with BMP-2 loaded functional nanoparticle-hydrogel complex. J Control Release 2007;121:91-99. (Pubitemid 47126068)
2. Chaudhary LR, Avioli LV. Extracellular-signal regulated kinase signaling pathway mediates downregulation of type I procollagen gene expression by FGF-2, PDGF-BB, and okadaic acid in osteoblastic cells. J Cell Biochem 2000;76:354-359.
3. Jackson RA, McDonald MM, Nurcombe V, Little DG, Cool SM. The use of heparan sulfate to augment fracture repair in a rat fracture model. J Orthop Res 2006;24:636-644. (Pubitemid 43804957)
4. Blanquaert F, Barritault D, Caruelle JP. Effects of heparan-like polymers associated with growth factors on osteoblast proliferation and phenotype expression. J Biomed Mater Res 1999;44:63-72. (Pubitemid 28544086)
5. Luong-Van E, Grøndahl L, Nurcombe V, Cool SM. In vitro biocompatibility and bioactivity of microencapsulated heparan sulfate. Biomaterials 2007;28:2127-2136.
6. Turnbull J, Powell A, Guimond S. Heparan sulfate: Decoding a dynamic multifunctional cell regulator. Trends Cell Biol 2001;11:75-82. (Pubitemid 32144754)
7. Nurcombe V, Smart CE, Chipperfield H, Cool SM, Boilly B, Hondermarck H. The proliferative and migratory activities of breast cancer cells can be differentially regulated by heparan sulfates. J Biol Chem 2000;275:30009-30018. (Pubitemid 30751305)
8. Tønnesen HH, Karlsen J. Alginate in drug delivery systems. Drug Dev Ind Pharm 2002;28:621-630.
9. Rees DA, Welsh EJ. Secondary and tertiary structure of polysaccharides in solution and gels. Angew Chem Int Ed Engl 1977;16:214-223.
10. Lin HR, Yeh YJ. Porous alginate/hydroxyapatite composite scaffolds for bone tissue engineering: Preparation, characterization, and in vitro studies. J Biomed Mater Res B: Appl Biomater 2004;71:52-65. (Pubitemid 39302662)
11. Zhang SM, Cui FZ, Liao SS, Zhu Y, Han L. Synthesis and biocompatibility of porous nano-hydroxyapatite/collagen/alginate composite. J Mater Sci Mater Med 2003;14:641-645. (Pubitemid 36851217)
12. Maruyama M, Terayama K, Ito M, Takei T, Kitagawa E. Hydroxyapatite clay for gap filling and adequate bone ingrowth. J Biomed Mater Res 1995;29:329-336.
13. Sivakumar M, Panduranga RK Preparation, characterization, and in vitro release of gentamicin from coralline hydroxyapatite-alginate composite microspheres. J Biomed Mater Res A 2003;65:222-228. (Pubitemid 37521428)
14. Krylova E, Ivanoc A, Orlovski V, El-Registan G, Barivon S. Hydroxyapatite-polysaccharide granules for drug delivery. J Mater Sci Mater Med 2002;13:87-90.
15. Paul W, Sharma CP. Infection resistant hydroxyapatite/alginate plastic composite. J Mater Sci Lett 1997;16:2050-2051. (Pubitemid 127504630)
16. Riberio CC, Barrias CC, Barbosa MA. Calcium phosphate-alginate microspheres as enzyme delivery matrices. Biomaterials 2004;25:4363-4373.
17. Hoffmann M, Huppertz B, Horres R, Keller R, Baumann H. Endothelial cell surface heparan sulfate (ESHS) and synthetic heparin derivatives as hemocompatible coating for biomaterials. Mat wiss u Werkstofftech 2001;32:110-115. (Pubitemid 33237039)
18. Luong-Van E, Grøndahl L, Chua K, Leong K, Nurcombe V, Cool S. Controlled release of heparin from poly(ε-caprolactone) electrospun fibers. Biomaterials 2006;27:2042-2050. (Pubitemid 41759498)
19. Grasdalen H, Larsen B, Smidsrød O. A PMR study of the composition and sequence of urinate residues in alginates. Carbohydrate Res 1979;68:23-31.
20. Tas AC. Synthesis of biomimetic Ca-hydroxyapatite powders at 37 degrees C in synthetic body fluids. Biomaterials 2000;21:1429-1438.
21. Wei M, Evans JH, Bostrom T, Grøndahl L. Synthesis and characterisation of hydroxyapatite, fluoride-substituted hydroxyapatite and fluorapatite. J Mater Sci Mater Med 2003;14:311-320. (Pubitemid 36437736)
22. Shilpa A, Agrawal SS, Ray AR. Controlled delivery of drugs from alginate matrix. J Mac Sci Polym Rev 2003;C43:187-221.
23. Lee HJ, Choi HW, Kim KJ, Lee SC. Modification of hydroxyapatite nanosurfaces for enhanced colloidal stability and improved interfacial adhesion in nanocomposites. Chem Mater 2006;18:5111-5118.
24. Jack KS, Vizcarra TG, Trau M. Characterisation and surface properties of amino-acid-modified carbonate-containing hydroxyapatite particles. Langmuir 2007;23:12233-12242. (Pubitemid 350197396)
25. Grant GT, Morris ER, Rees DA, Smith PJC, Thom D. Biological interactions between polysaccharides and divalent cations: Egg-box model. FEBS Lett 1973;32:195-198.
26. Fundueanu G, Nastruzzi C, Carpov A, Desbrieres J, Rinaudo M. Physico-chemical characterization of Ca-alginate microparticles produced with different methods. Biomaterials 1999;20:1427-1435. (Pubitemid 29326814)
27. 2+-alginate beads. Biotechnol Bioeng 2002;79:253-259.
28. Rees SG, Wassell DTH, Embery G. Interaction of glucoronic acid and iduronic acid-rich glycosaminoglycans and their modified forms with hydroxyapatite. Biomaterials 2002;23:481-489. (Pubitemid 33051036)
29. Sikorski P, Mo F, Skjåk-Bræk G, Stokke BT. Evidence for eggbox-compatible interactions in calcium-alginate gels from fiber x-ray diffraction. Biomacromolecules 2007;8:2098-2103.
30. 2+ binding site. Eur J Org Chem 2002;14:2367-2376.
31. Grant D, Moffat CF, Long WF, Williamson FB. Optical rotation changes in chemically modified heparins as a guide to anionic groups involved in calcium binding. Biochem Soc Trans 1991;19:S393.
32. Arica B, Calis S, Kas HS, Sargon MF, Hincal AA. 5-Flurouracil encapsulated alginate beads for the treatment of breast cancer. Int J Pharm 2002;242:267-269. (Pubitemid 34899470)
33. Martell AE, Smith RM. Critical Stability Constants. New York: Plenum Press; 1974.
34. Kokubo T, Kushitani H, Sakka S, Kitsugi T, Yamamuro T. Solutions able to reproduce in vivo surface-structure changes in bioactive glass-ceramic A-W. J Biomed Mater Res 1990;24:721-734. (Pubitemid 20236523)
35. Misra DN. Adsorption of polyacrylic acids and their sodium salts on hydroxyapatite: Effect of relative molar mass. J Colloid Interface Sci 1996;181:289-296.
36. Malkaj P, Pierre E, Dalas E. The crystallization of Hydroxyapatite in the presence of sodium alginate. J Mater Sci Mater Med 2005;16:733-737. (Pubitemid 40909698)
37. Downs EC, Robertson NE, Riss TL, Plunkett ML. Calcium alginate beads as slow-release system for delivering angiogenic molecules in vivo and in vitro. J Cell Physiol 1992;152:422-429.
38. Bowersock TL, HogenEsch H, Suckow M, Porter RE, Jackson R, Park H, Park K. Oral vaccination with alginate microsphere systems. J Control Release 1996;39:209-220. (Pubitemid 26194220)
39. Yasuhiko T. Tissue regeneration based on growth factor release. Tissue Eng 2003;9:S5-S15. (Pubitemid 37046603)
40. Gu F, Amsden B, Neufeld R. Sustained delivery of vascular endothelial growth factor with alginate beads. J Control Release 2004;96:463-472. (Pubitemid 38553924)
41. Fathy M, Safwat SM, El-Shanawany SM, Shawky Tous S, Otagiri M. Preparation and evaluation of beads made of different calcium alginate compositions for oral sustained release of tiaramide. Pharm Dev Tech 1998;3:355-364. (Pubitemid 28410363)
42. Ho J, Neufeld RJ. Retention and release of low molecular weight DNAfrom alginate beads. STP Pharma Sci 2001;11: 109-115. (Pubitemid 32154866)
43. McLennan G, Johnson MS, Stookey KR, Zhang Z, Fife WK. Kinetics of release of heparin from alginate hydrogel. JVIR 2002;11:1087-1094. (Pubitemid 30736632)
44. Douglas KL, Tabrizian M. Effect of experimental parameters on the formation of alginate-chitosan nanoparticles and evaluation of their potential application as DNA carrier. J Biomater Sci Polymer Ed 2005;16:43-56. (Pubitemid 41149195)
45. Chandy T, Rao GHR, Wilson RF, Das GS. Delivery of LMW Heparin via surface coated chitosan/peg-alginate microspheres prevents thrombosis. Drug Deliv 2002;9:87-96. (Pubitemid 34606532)
46. Hoffman AS. Hydrogels for biomedical applications. Adv Drug Del Rev 2002;43:3-12.
47. Mizushima Y, Ikoma T, Tanaka J, Hoshi K, Ishihara T, Ogawa Y, Ueno A. Injectable porous hydroxyapatite microparticles as a new carrier for protein and lipophilic drugs. J Control Release 2006;110:260-265. (Pubitemid 41829564)
48. Gbureck U, Vorndran E, Müller FA, Barralet JE. Low temperature direct 3D printed bioceramics and biocomposites as drug release matrices. J Control Release 2007;122:173-180. (Pubitemid 47364748)